[go: up one dir, main page]

HK1214158A1 - 治療澱粉樣變性的製劑和方法 - Google Patents

治療澱粉樣變性的製劑和方法

Info

Publication number
HK1214158A1
HK1214158A1 HK16102216.6A HK16102216A HK1214158A1 HK 1214158 A1 HK1214158 A1 HK 1214158A1 HK 16102216 A HK16102216 A HK 16102216A HK 1214158 A1 HK1214158 A1 HK 1214158A1
Authority
HK
Hong Kong
Prior art keywords
formulations
methods
treating amyloidosis
amyloidosis
treating
Prior art date
Application number
HK16102216.6A
Other languages
English (en)
Inventor
Denis Garceau
Wendy Hauck
Richard Briand
Original Assignee
Kiacta Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kiacta Srl filed Critical Kiacta Srl
Publication of HK1214158A1 publication Critical patent/HK1214158A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
HK16102216.6A 2005-04-15 2016-02-26 治療澱粉樣變性的製劑和方法 HK1214158A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67186605P 2005-04-15 2005-04-15

Publications (1)

Publication Number Publication Date
HK1214158A1 true HK1214158A1 (zh) 2016-07-22

Family

ID=37499595

Family Applications (2)

Application Number Title Priority Date Filing Date
HK08108559.8A HK1116686A1 (zh) 2005-04-15 2008-08-01 用於治療澱粉樣變性的製劑和方法
HK16102216.6A HK1214158A1 (zh) 2005-04-15 2016-02-26 治療澱粉樣變性的製劑和方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK08108559.8A HK1116686A1 (zh) 2005-04-15 2008-08-01 用於治療澱粉樣變性的製劑和方法

Country Status (25)

Country Link
US (3) US8178580B2 (zh)
EP (2) EP2944308A1 (zh)
JP (2) JP2008535906A (zh)
KR (2) KR20080003895A (zh)
CN (2) CN101528216A (zh)
AU (1) AU2006264498B2 (zh)
BR (1) BRPI0610592A2 (zh)
CA (1) CA2582556C (zh)
DK (1) DK1885350T3 (zh)
EA (1) EA018898B1 (zh)
ES (1) ES2534553T3 (zh)
HK (2) HK1116686A1 (zh)
HR (1) HRP20150320T1 (zh)
HU (1) HUE026044T2 (zh)
IL (2) IL186544A (zh)
ME (1) ME02149B (zh)
MX (1) MX2007012525A (zh)
NO (1) NO20075815L (zh)
PL (1) PL1885350T3 (zh)
PT (1) PT1885350E (zh)
RS (1) RS54050B1 (zh)
SI (1) SI1885350T1 (zh)
TW (1) TW200716088A (zh)
WO (1) WO2007004072A2 (zh)
ZA (1) ZA200709825B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5994900A (en) * 1999-07-09 2001-01-30 Isis Innovation Limited Compounds for inhibiting diseases and preparing cells for transplantation
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
EP1836161B1 (en) 2004-12-22 2016-07-20 BHI Limited Partnership Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
WO2007023389A2 (en) * 2005-07-21 2007-03-01 Neurochem (International) Limited Polymorphic forms of 3-amino-1-propanesulfonic acid
BRPI0620637A2 (pt) 2005-12-22 2011-11-16 Neurochem Int Ltd uso de compostos na preparação de medicamentos para a prevenção ou o tratamento de nefropatia diabética, complicação de desordem renal e dislipidemia, redução dos nìveis de lipìdeos e ácido úrico no soro, e aumento do clearance de creatinina e da função renal
WO2009019534A2 (en) 2006-10-12 2009-02-12 Bellus Health (International) Limited Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
EP2120905A1 (en) * 2006-12-22 2009-11-25 BELLUS Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
EP2464626A4 (en) 2009-08-10 2015-12-16 Bhi Ltd Partnership PROCESSES, COMPOUNDS AND COMPOSITIONS FOR THE EXPORTS OF 1,3-PROPANE-SULFONIC ACID
JP6049623B2 (ja) 2010-10-22 2016-12-21 カッパーアールエヌエー，インコーポレイテッド α‐Ｌ‐イズロニダーゼ（ＩＤＵＡ）への天然アンチセンス転写物の阻害によるＩＤＵＡ関連疾患の治療
CN109730988A (zh) * 2014-04-30 2019-05-10 伊坎西奈山医学院 1，3-丙二磺酸或其药学上可接受的盐用于治疗肉样瘤病的用途
WO2016023911A1 (en) * 2014-08-11 2016-02-18 Kiacta Sàrl Use of 1,3-propanedisulfonic acid or salts thereof to prevent the onset of amyloidosis in select populations
CN116143672B (zh) * 2023-02-28 2024-03-29 卫星化学股份有限公司 水溶性抗氧剂及其制备方法和应用

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2531468A (en) * 1949-04-14 1950-11-28 Eastman Kodak Co Polyvinyl sulfonates and process for their preparation
DE1122064B (de) * 1960-01-09 1962-01-18 Basf Ag Verfahren zur Einfuehrung von alyphatischen Kohlenwasserstoffresten in organische Verbindungen, die Hydroxylgruppen, tertiaere Aminogruppen, aromatische gebundene Sulfhydrylgruppen und bzw. oder aromatisch gebundene primaere oder sekundaere Aminogruppen enthalten
US3218352A (en) * 1962-05-03 1965-11-16 Abbott Lab Homotaurine process
US3658966A (en) * 1969-09-15 1972-04-25 Kowa Co Methods of treating hypertension
US3920833A (en) * 1974-08-08 1975-11-18 Stanley Drug Products Inc Antifibrinolytic agents
FR2437834A1 (fr) 1978-10-04 1980-04-30 Lejeune Jerome Compositions pharmaceutiques a base de l-serine ou de glycine
FR2457281A1 (fr) * 1979-05-23 1980-12-19 Meram Lab Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee
US4255448A (en) * 1979-09-10 1981-03-10 Wisconsin Alumni Research Foundation Method for reducing epileptiform activity
US4448779A (en) * 1981-07-16 1984-05-15 Sanofi Use of MS salt in geriatric medicine
JPS5879022A (ja) * 1981-11-04 1983-05-12 Bitamin Kenkyusho:Kk 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤
US4657704A (en) 1982-09-08 1987-04-14 Mitsui Toatsu Chemicals, Incorporated Production of aminoalkylsulfonic acids
US4737353A (en) * 1984-04-13 1988-04-12 Union Carbide Corporation Beryllium-aluminum-phosphorus-silicon-oxide molecular sieve compositions
IT1173990B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale
JPH0733332B2 (ja) * 1985-11-19 1995-04-12 富山化学工業株式会社 痴呆症状改善・治療剤
JPH0786122B2 (ja) * 1986-05-30 1995-09-20 日本ペイント株式会社 三次元架橋された微小樹脂粒子およびその製造法
US4847082A (en) * 1987-01-21 1989-07-11 Robert Sabin Method of treatment of Alzheimer's disease using phytic acid
IT1205042B (it) 1987-05-28 1989-03-10 Crinos Industria Farmaco Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer
IT1211792B (it) 1987-09-21 1989-11-03 Sigma Tau Ind Farmaceuti O-alcanoil derivati dell'acido 3ammino-2-idrossipropansolfonico adattivita'anticonvulsivante e loro composizioni farmaceutiche per il trattamento terapeutico dell'epilessia
JPH01171638A (ja) 1987-12-25 1989-07-06 Kanegafuchi Chem Ind Co Ltd 血清アミロイドａ蛋白用吸着体
JP2587842B2 (ja) 1987-12-09 1997-03-05 株式会社ニチレイ 神経疾患治療・予防剤
IT1212000B (it) 1987-12-24 1989-11-08 Sigma Tau Ind Farmaceuti Fenilbenziliden-derivati dell'acido 3)amminopropansolfonico ad attivita' anticonvulsivante e loro composizioni farmaceutiche per il trattamento terapeutico della epilessia
US4968678A (en) 1988-02-19 1990-11-06 Eli Lilly And Company Tetrazole excitatory amino acid receptor antagonists
ZA891113B (en) 1988-02-19 1990-10-31 Lilly Co Eli Tetrazole excitatory amino acid receptor antagonists
JPH0627072B2 (ja) 1988-09-13 1994-04-13 呉羽化学工業株式会社 アミノ安息香酸誘導体を有効成分とする生体内抗酸化機構調節剤
JPH0667472B2 (ja) 1988-11-28 1994-08-31 鐘淵化学工業株式会社 血清アミロイドｐ蛋白用吸着体
US5061721A (en) 1989-03-15 1991-10-29 G. D. Searle & Co. Composition containing d-cycloserine and d-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder
JP2761048B2 (ja) 1989-08-25 1998-06-04 三共株式会社 神経成長因子産生促進剤
DE4004978A1 (de) 1990-02-19 1991-08-22 Nmi Naturwissenschaftl U Mediz Praeventive therapie fuer morbus alzheimer
JP2780846B2 (ja) 1990-05-01 1998-07-30 インペリアル・ケミカル・インダストリーズ・ピーエルシー 除草剤組成物
US5242932A (en) * 1991-12-17 1993-09-07 The Rockefeller University Treatment of amyloidosis associated with alzheimer disease
JPH0725786A (ja) 1990-05-16 1995-01-27 Univ Rockefeller アルツハイマー病を伴うアミロイドーシスの治療
US5385915A (en) * 1990-05-16 1995-01-31 The Rockefeller University Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation
DE4021066A1 (de) 1990-07-03 1992-01-09 Hoechst Ag Langzeitprophylaxe gegen erkrankungen, die durch viren oder durch unkonventionelle viren verursacht werden
DE69125216T2 (de) * 1990-07-19 1997-09-25 Nippon Zoki Pharmaceutical Co Aminoalkanesulfonsäurederivate und pharmazeutische Zusammensetzungen davon zur Prävention oder Behandlung von Herzerkrankungen
JP2980749B2 (ja) 1990-11-30 1999-11-22 協和醗酵工業株式会社 フラン誘導体
US6746678B1 (en) * 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
US5164295A (en) * 1991-03-06 1992-11-17 The Upjohn Company Method for identifying amyloid protein-extracellular matrix protein affinity altering compounds
US6277969B1 (en) 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US5192753A (en) * 1991-04-23 1993-03-09 Mcgeer Patrick L Anti-rheumatoid arthritic drugs in the treatment of dementia
GB9117716D0 (en) 1991-08-16 1991-10-02 Lynxvale Ltd Gaba derivatives and their therapeutic application
DK0548024T3 (da) * 1991-12-19 1997-01-27 Ciba Geigy Ag Aminosulfonsyrederivater samt fremgangsmåder til deres fremstilling
US5318958A (en) * 1992-05-29 1994-06-07 Queen's University At Kingston Amyloid precursor protein
US5837672A (en) * 1992-07-10 1998-11-17 Athena Neurosciences, Inc. Methods and compositions for the detection of soluble β-amyloid peptide
US5276059A (en) * 1992-07-10 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of diseases associated with amyloid formation
US5840294A (en) * 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
CA2159326C (en) 1993-03-29 2000-05-30 Robert Kisilevsky Method for treating amyloidosis
US5643562A (en) * 1993-03-29 1997-07-01 Queen's University Of Kingston Method for treating amyloidosis
US5972328A (en) * 1993-03-29 1999-10-26 Queen's University At Kingston Method for treating amyloidosis
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
AU7376494A (en) 1993-08-04 1995-02-28 Andrulis Pharmaceuticals Corporation Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents
US5488145A (en) * 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
US5858326A (en) * 1995-06-06 1999-01-12 Neurochem, Inc. Methods of increasing amyloid deposition
AU703540B2 (en) 1996-03-26 1999-03-25 Meddiss, Incorporated Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
CA2217322C (en) * 1996-10-03 2005-01-04 Coastside Bio Resources Inhibition of complement pathway by sea cucumber fractions
US6306909B1 (en) * 1997-03-12 2001-10-23 Queen's University At Kingston Anti-epileptogenic agents
US5869469A (en) * 1997-08-18 1999-02-09 Queen's University At Kingston Phosphonocarboxylate compounds for treating amyloidosis
US6294583B1 (en) * 1998-01-13 2001-09-25 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders
DK1054664T3 (da) * 1998-02-11 2012-11-05 Bhi Ltd Partnership Fremgangsmåde til modulering af makrofagaktivering
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
US6329356B1 (en) * 1998-04-10 2001-12-11 Neurochem, Inc. Phosphono-carboxylate compounds for treating amyloidosis
US20030147882A1 (en) * 1998-05-21 2003-08-07 Alan Solomon Methods for amyloid removal using anti-amyloid antibodies
US6310073B1 (en) * 1998-07-28 2001-10-30 Queen's University At Kingston Methods and compositions to treat glycosaminoglycan-associated molecular interactions
WO2000027807A1 (en) * 1998-11-10 2000-05-18 Neurochem, Inc. Polymorphic forms of an amyloidosis inhibitor and methods of preparation
KR100822525B1 (ko) 1999-04-28 2008-04-16 뉴로겜 인터내셔널 리미티드 아밀로이드증 치료용 조성물 및 방법
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
AU5994900A (en) * 1999-07-09 2001-01-30 Isis Innovation Limited Compounds for inhibiting diseases and preparing cells for transplantation
KR20080003945A (ko) * 1999-12-23 2008-01-08 뉴로겜 인터내셔널 리미티드 대뇌 아밀로이드 혈관병증을 조절하는 화합물 및 방법
US6376557B1 (en) * 2000-03-16 2002-04-23 Chanda Bhuwalka Zaveri Methods for treating alopecia
US20020115717A1 (en) * 2000-07-25 2002-08-22 Francine Gervais Amyloid targeting imaging agents and uses thereof
US7311893B2 (en) * 2000-07-25 2007-12-25 Neurochem (International) Limited Amyloid targeting imaging agents and uses thereof
US20020151506A1 (en) * 2000-12-29 2002-10-17 Castillo Gerardo M. Catechins for the treatment of fibrillogenesis in Alzheimer's disease, Parkinson's disease, systemic AA amyloidosis, and other amyloid disorders
PL362687A1 (en) * 2001-01-12 2004-11-02 Sun Pharmaceutical Industries Limited Spaced drug delivery system
IL157845A0 (en) * 2001-03-13 2004-03-28 Univ Kingston Anti-epileptogenic agents
US7501429B2 (en) * 2001-04-11 2009-03-10 Queen's University At Kingston Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
JP2004536071A (ja) * 2001-05-25 2004-12-02 クイーンズ　ユニバーシティ　アット　キングストン 複素環ベータアミノ酸およびそれらの抗癲癇誘発剤としての使用
KR20040036908A (ko) * 2001-08-31 2004-05-03 뉴로겜 인터내셔널 리미티드 아밀로이드증 치료용 아미딘 유도체
CA2399169A1 (en) * 2001-09-07 2003-03-07 Queen's University At Kingston Diagnostic methods for determining susceptibility to convulsive conditions
CA2511599A1 (en) 2002-12-24 2004-07-15 Neurochem (International) Limited Therapeutic formulations for the treatment of beta-amyloid related diseases
US20050031651A1 (en) * 2002-12-24 2005-02-10 Francine Gervais Therapeutic formulations for the treatment of beta-amyloid related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20050142191A1 (en) * 2003-06-23 2005-06-30 Neurochem (International) Limited Pharmaceutical formulations of amyloid inhibiting compounds
US20050215562A1 (en) * 2003-06-23 2005-09-29 Patrick Tremblay Methods for treating protein aggregation disorders
CA2529269C (en) * 2003-06-23 2012-02-07 Neurochem (International) Limited Improved pharmaceutical drug candidates and methods for preparation thereof
US20050038000A1 (en) * 2003-06-23 2005-02-17 Xianqi Kong Methods and compositions for the treatment of amyloid-and epileptogenesis-associated diseases
US7253306B2 (en) * 2003-06-23 2007-08-07 Neurochem (International) Limited Pharmaceutical drug candidates and methods for preparation thereof
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
US20080038192A1 (en) * 2004-07-19 2008-02-14 Neurochem Inc. Diagnostic Methods Of Multiple Organ Amyloidosis
CA2586111A1 (en) * 2004-11-12 2006-06-08 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
EP1817305A2 (en) * 2004-11-16 2007-08-15 Neurochem (International) Limited Compounds for the treatment of cns and amyloid associated diseases
EP1836161B1 (en) * 2004-12-22 2016-07-20 BHI Limited Partnership Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis

Also Published As

Publication number Publication date
TW200716088A (en) 2007-05-01
BRPI0610592A2 (pt) 2010-07-06
US8178580B2 (en) 2012-05-15
ME02149B (me) 2015-10-20
ES2534553T3 (es) 2015-04-24
PT1885350E (pt) 2015-04-29
US20120270939A1 (en) 2012-10-25
EA200702237A1 (ru) 2008-06-30
KR20080003895A (ko) 2008-01-08
SI1885350T1 (sl) 2015-06-30
NO20075815L (no) 2008-01-11
IL186544A (en) 2014-02-27
ZA200709825B (en) 2009-04-29
HUE026044T2 (en) 2016-05-30
KR20130133915A (ko) 2013-12-09
US20130296434A1 (en) 2013-11-07
DK1885350T3 (en) 2015-05-26
WO2007004072A2 (en) 2007-01-11
US20060252829A1 (en) 2006-11-09
CN101528216A (zh) 2009-09-09
IL230935A0 (en) 2014-03-31
CN104873483A (zh) 2015-09-02
JP2013079260A (ja) 2013-05-02
AU2006264498B2 (en) 2012-09-27
CA2582556A1 (en) 2007-01-11
IL186544A0 (en) 2008-08-07
JP5753152B2 (ja) 2015-07-22
EP2944308A1 (en) 2015-11-18
EA018898B1 (ru) 2013-11-29
WO2007004072A3 (en) 2007-08-23
AU2006264498A1 (en) 2007-01-11
HRP20150320T1 (en) 2015-07-03
PL1885350T3 (pl) 2015-08-31
JP2008535906A (ja) 2008-09-04
EP1885350A2 (en) 2008-02-13
EP1885350B9 (en) 2015-06-17
EP1885350B1 (en) 2015-03-04
ES2534553T9 (es) 2015-06-25
HK1116686A1 (zh) 2009-01-02
WO2007004072B1 (en) 2007-12-27
RS54050B1 (en) 2015-10-30
MX2007012525A (es) 2007-12-06
CA2582556C (en) 2012-05-29

Similar Documents

Publication Publication Date Title
HK1214158A1 (zh) 治療澱粉樣變性的製劑和方法
IL186973A0 (en) Compositions and methods for treatment for neoplasms
GB2423928B (en) Methods and compositions for treating pain
IL186963A0 (en) Methods and compositions for treating pain
IL185540A0 (en) Compositions and methods for treating acne
EP1890712A4 (en) COMPOSITIONS AND METHODS FOR TREATING PAIN
EP1959929A4 (en) COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL SUFFERING
EP1940437A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF BACTERIA
EP1737482A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
HK1121952A1 (en) Methods and compositions for treating conditions
HK1123509A1 (en) Hair treatment compositions
IL186599A0 (en) Methods for treating and preventing fibrosis
IL191072A0 (en) Therapeutic compositions and methods
EP1959931A4 (en) COMPOSITIONS AND METHODS FOR THE DERMAL TREATMENT OF PAIN
ZA200608932B (en) Method and compositions for epilation
IL186408A0 (en) Combination treatment methods
IL176919A0 (en) Methods and compositions for treating cancer
ZA200705297B (en) Methods and compositions for treating amyloid related diseases
ZA200803524B (en) Hair treatment compositions
ZA200803523B (en) Hair treatment compositions
IL191237A0 (en) Compositions and methods for treating thrombocytopenia
EP1855662A4 (en) METHODS AND COMPOSITIONS FOR TREATING CANCER
EP1841397A4 (en) TRICHOLOGY FORMULATIONS AND TREATMENTS
ZA200608935B (en) Methods and compositions for epilation
GB0500451D0 (en) Hair treatment apparatus